Objective Hepatic metastases from soft-tissue sarcoma are evaluated to
define treatment and its limitations. Methods From 981 adult patients
with diagnoses of soft-tissue sarcoma, 65 patients with hepatic metas
tases were studied. Results An intra-abdominal primary site was presen
t in 61 of 65 patients, with 85% high-grade leiomyosarcoma. Hepatic re
section was performed in 14 patients (22%). All patients have had recu
rrences after hepatic resection-11 of 14 in the liver-with a median su
rvival of 30 months. Chemotherapy resulted in partial response in thre
e patients and no complete responses. Survival is not influenced by gr
ade, type, primary site, disease-free interval, chemotherapy, or hepat
ic resection. Conclusions The uncommon response to conventional chemot
herapy does not support its use in the treatment of hepatic metastases
from soft-tissue sarcoma. Extent of disease limits the application an
d success of hepatic resection for soft-tissue sarcoma, and anything l
ess than complete resection is not indicated.